Cargando…
Paediatric Medicines in Europe: The Paediatric Regulation—Is It Time for Reform?
Objectives: In this paper, we investigated the effects of the European Paediatric Regulation (EC) N° 1901/2006 with respect to satisfying the paediatric therapeutic needs, assessed in terms of the increased number of paediatric medicinal products, new therapeutic indications in specific high-need co...
Autores principales: | Toma, Maddalena, Felisi, Mariagrazia, Bonifazi, Donato, Bonifazi, Fedele, Giannuzzi, Viviana, Reggiardo, Giorgio, de Wildt, Saskia, Ceci, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884470/ https://www.ncbi.nlm.nih.gov/pubmed/33604345 http://dx.doi.org/10.3389/fmed.2021.593281 |
Ejemplares similares
-
Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project
por: Giannuzzi, Viviana, et al.
Publicado: (2021) -
Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs
por: Giannuzzi, Viviana, et al.
Publicado: (2017) -
Paediatric clinical research in Europe: an insight on experts’ needs and perspectives
por: Ruggieri, Lucia, et al.
Publicado: (2021) -
Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen
por: Giannuzzi, Viviana, et al.
Publicado: (2017) -
Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed
por: Ceci, Adriana, et al.
Publicado: (2023)